Plus Therapeutics
PSTV
PSTV was delisted on the 31st of July, 2026.
11 hedge funds and large institutions have $247K invested in Plus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
110% more capital invested
Capital invested by funds: $118K → $247K (+$130K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
10% more funds holding
Funds holding: 10 → 11 (+1)
0% more ownership
Funds ownership: 0.12% → 0.12% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$52.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$27K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26.2K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$22.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$26.5K |
| 2 |
HF
HRT Financial
New York
|
-$15K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.4K |
| 4 |
Citigroup
New York
|
-$776 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $58K | +$52.9K | +1,320 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $57K | +$26.2K | +654 | +101% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $47.5K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $30.1K | +$27K | +674 | New |
|
|
GSC
5
Ground Swell Capital
Folly Beach,
South Carolina
| $25.6K | +$22.9K | +572 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $15.6K | +$6.01K | +150 | +73% |
|
7
BlackRock
New York
| $12.2K | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $1K | -$1.4K | -35 | -60% |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $232 | – | – | – |
|
10
JP Morgan Chase
New York
| $177 | +$160 | +4 | New |
|
11
Wells Fargo
San Francisco,
California
| $61 | – | – | – |
|
12
Group One Trading
Chicago,
Illinois
| $2 | – | – | – |
|
|
13
Millennium Management
New York
| – | -$26.5K | -790 | Closed |
|
|
HF
14
HRT Financial
New York
| – | -$15K | -449 | Closed |
|
|
15
Citigroup
New York
| – | -$776 | -23 | Closed |
|
PSTV Hedge Fund Activity: Q4 2023 in Review
11 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q4 2023, worth a combined $247K — up 110% from $118K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PSTV positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $52.9K. The largest seller was Millennium Management, exiting entirely with an estimated $26.5K sold.
- 11 institutional investors held Plus Therapeutics (PSTV) as of Q4 2023, up from 10 in Q3 2023.
- Funds reported $247K of Plus Therapeutics stock for Q4 2023, up 110% quarter-over-quarter.
- 4 funds opened new Plus Therapeutics positions in Q4 2023 and 3 closed out, a net change of +1 holder.
- The largest Plus Therapeutics buyer in Q4 2023 was Renaissance Technologies, an estimated $52.9K added.
- The largest Plus Therapeutics seller in Q4 2023 was Millennium Management, an estimated $26.5K sold.
Based on aggregated 13F filings for Q4 2023.